Abstract:BACKGROUND:The blood-brain barrier (BBB) maintains the balance of the internal environment of the brain and strictly controls substance exchange between the brain and blood dynamically but stably. Transient increases in the permeability of the BBB plays an important role in helping macromolecular drugs enter the brain to exert their pharmacological effects. Previous research has revealed that electronic acupuncture (EA) stimulation connecting Baihui (GV20) and Shuigou (GV26) at a specific frequency can enhance the permeability of the BBB at 8 minutes after the intervention and induce the entry of 20 kDa fluorescein isothiocyanate-dextran (FITC-dextran) into the cerebral cortex, but whether it can also allow drugs to pass the BBB remains unknown. We hypothesized that EA at a specific frequency could open the BBB and induce the entry of nerve growth factor (NGF) into the brain to exert its therapeutic effect.METHODS:First, the middle cerebral artery occlusion (MCAO) model is adopted and changes in the permeability and structure of the BBB are assessed by measuring both the intensity of Evans blue (EB) staining and the cerebral infarction volume, and by evaluating the ultrastructure of the BBB. Then, a laser spectrometer and immunofluorescence are used to observe entry of NGF into the brain. Finally, the learning and memory ability of rats are assessed and the DeadEndTM Fluorometric TUNEL System is applied to assess apoptosis in the hippocampus.RESULTS:Our results showed that, in the first, the BBB was essentially repaired three weeks after MCAO operation. Secondly, Electronic Acupuncture (EA) stimulation at a specific frequency can enhance BBB permeability in the prefrontal cortex and induce NGF uptake by prefrontal neurons. Finally, in the presence of EA stimulation, entry of NGF into the brain promoted learning and memory in rats and inhibited the apoptosis of neurons in the hippocampus.CONCLUSIONS:In this study, the timing of BBB repair in the MCAO model was determined under pathological conditions and the EA stimulation can induce the entry of NGF into the brain to exert its therapeutic effect. EA could serve as a new strategy for delivering therapeutics to the central nervous system (CNS), given that EA stimulation at a specific frequency was shown to increase the permeability of the BBB. Further study of the mechanism underlying the opening of the BBB and its timing is needed.

Study on transportation of nerve growth factor-polybutylcyanoacrylate-nanoparticles across blood-brain barriers of rat

Nanoparticles Improve the Passage of Nerve Growth Factor Through Blood-Brain Barrier by Stimulating Aβ Clearance

Nanoparticles Improve the Passage of Nerve Growth Factor Through Blood-Brain Barrier by Stimulating A β Clearance

The Influence of Electronic Acupuncture at A Specific Frequency in Facilitating the Passage of NGF Through the Blood-Brain Barrier and Its Effect on Learning and Memory in MCAO/R Rats

Study on treatment of AD by NGF liposomes via nasal administration

Intranasal Nanoparticles of Basic Fibroblast Growth Factor for Brain Delivery to Treat Alzheimer'S Disease

Poly(butyl cyanoacrylate) nanoparticles-delivered β-nerve growth factor promotes the neurite outgrowth and reduces the mortality in the rat after traumatic brain injury

Poly(butyl Cyanoacrylate) Nanoparticles-Deliveredβ-nerve Growth Factor Promotes the Neurite Outgrowth and Reduces the Mortality in the Rat after Traumatic Brain Injury.

Erythrocyte membrane-coated nanocarriers modified by TGN for Alzheimer's disease

Brain Delivery of NAP with PEG-PLGA Nanoparticles Modified with Phage Display Peptides

PLGA Nanoparticles Modified with a BBB-penetrating Peptide Co-Delivering Aβ Generation Inhibitor and Curcumin Attenuate Memory Deficits and Neuropathology in Alzheimer's Disease Mice.

(1)H-MRS Evaluation of Therapeutic Effect of Neural Stem Cell Transplantation on Alzheimer's Disease in AβPP/PS1 Double Transgenic Mice.

Intranasal administration of nerve growth factor ameliorate β-amyloid deposition after traumatic brain injury in rats.

Effect of Nerve Growth Factor Delivering Intranasally on Β-Amyloid Deposition after Traumatic Brain Injury in Rats

Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of β-amyloid and ibotenic acid into the bilateral hippocampus.

Blood-brain barrier Permeable nanoparticles for Alzheimer's disease treatment by selective mitophagy of microglia

Intelligently Thermoresponsive Flower-Like Hollow Nano-Ruthenium System for Sustained Release of Nerve Growth Factor to Inhibit Hyperphosphorylation of Tau and Neuronal Damage for the Treatment of Alzheimer's Disease

Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease

Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer

Penetratin Peptide-Functionalized Gold Nanostars: Enhanced Bbb Permeability and Nir Photothermal Treatment of Alzheimer'S Disease Using Ultralow Irradiance

Glucose-modified BSA/procyanidin C1 NPs penetrate the blood-brain barrier and alleviate neuroinflammation in Alzheimer's disease models